logo_centered_440x386.png
PacBio Announces the HiFi Solves Sub-fertility Consortium in Asia Pacific
September 11, 2024 09:05 ET | PacBio
SINGAPORE, Sept. 11, 2024 (GLOBE NEWSWIRE) -- The HiFi Solves Sub-fertility Consortium, an innovative collaboration involving five leading centers across the Asia-Pacific region, announces work...
logo_centered_440x386.png
Revio to Power Research in Male Infertility and Rare Disease at Münster University Hospital
September 04, 2024 09:05 ET | PacBio
MENLO PARK, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced a collaboration with the...
logo_centered_440x386.png
PacBio to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
August 26, 2024 16:03 ET | PacBio
MENLO PARK, Calif., Aug. 26, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will...
logo_centered_440x386.png
PacBio Announces Second Quarter 2024 Financial Results
August 07, 2024 16:05 ET | PacBio
MENLO PARK, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2024. Second quarter results: Revenue of $36.0 million...
logo_centered_440x386.png
Singapore’s National Precision Medicine (NPM) programme will partner with PacBio to propel HiFi Sequencing in Southeast Asia
August 05, 2024 16:05 ET | PacBio
SINGAPORE, Aug. 05, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced that Precision Health Research, Singapore...
logo_centered_440x386.png
Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing
July 23, 2024 09:05 ET | PacBio
MENLO PARK, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that Novogene is using its...
logo_centered_440x386.png
PacBio to Report Second Quarter 2024 Financial Results on August 7, 2024
July 15, 2024 16:03 ET | PacBio
MENLO PARK, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2024 financial results on...
logo_centered_440x386.png
PacBio Grants Equity Incentive Award to New Employee
June 27, 2022 20:00 ET | PacBio
MENLO PARK, Calif., June 27, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee...
logo_centered_440x386.png
PacBio Collaborates with iLAC and Robotic Biology Institute to Develop Automated Workflows
May 08, 2022 19:00 ET | PacBio
MENLO PARK, Calif., TOKYO, May 09, 2022 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced a collaboration with...
logo_centered_440x386.png
パックバイオ (PacBio)、iLACおよびロボティック・バイオロジー・インスティテュート株式会社 (Robotic Biology Institute) と共同で自動化ワークフローを開発
May 08, 2022 19:00 ET | Pacific Biosciences of California, Inc.
カリフォルニア州メンローパークおよび東京発, May 09, 2022 (GLOBE NEWSWIRE) -- 高品質・高精度のシーケンシングソリューションのリーディングカンパニーであるパックバイオ (PacBio) (NASDAQ: PACB) は、ゲノム解析企業である株式会社アイラック (iLAC, Inc.)、およびロボティック・バイオロジー・インスティテュート株式会社 (Robotic...